Navigation Links
WellPoint's Contribution To Drug Formulary Evaluation Standards Highlighted in ISPOR Publication
Date:7/2/2009

WellPoint is one of few in the industry providing public access to formulary evaluation standards

INDIANAPOLIS, July 2 /PRNewswire-FirstCall/ -- WellPoint Inc.'s (NYSE: WLP) contribution to creating evidence-based formulary evaluation standards is discussed in the June edition of Value in Health, the journal of the International Society for Pharmacoeconomics and Outcomes Research.

WellPoint is one of few health care management companies that publicly shares its standards on how it establishes its formulary, according to the article, entitled, "Health Technology Assessment in Health-Care Decisions in the United States." The standards are accessible by going to https://www.wellpointnextrx.com/wps/portal/wpo/consultant/druglist/consultantpharmacytherapeutics.

The article was authored by the University of Washington's Sean Sullivan and Scott Ramsey, Premera Blue Cross' John Watkins and WellPoint Chief Clinical Pharmacy Officer Brian Sweet. The publication was funded by a small honorarium from the International Society for Pharmacoeconomics and Outcomes Research.

The authors predict that these evidence-based standards--known as health technology assessment guidelines--will be pushed into a new realm as new evidence is generated from comparative effectiveness research.

"Much of the existing research we have on products is based on how the product performs against a placebo," said Sweet. "That simply isn't enough to ensure that every person gets the treatment that is best for him or her. To improve the quality of health care and to reduce medical costs, we need to know which approach works best and for whom. Comparative effectiveness research can provide additional evidence to be used in formulary evaluations to ensure we make the best health care decisions for our members."

WellPoint revised its evidence requirements for pharmaceutical technology assessments in October, 2008, and shared information about the type of data the company is using to make healthcare decisions on drug therapy with the pharmaceutical and biotechnology industries.

The WellPoint Outcomes-Based Formulary process includes specific requirements for new products, new indications and new formulations and the re-evaluation of products, indications and formulations. Specifically, it asks pharmaceutical manufacturers to provide the following:

  • Impact on patient-reported outcomes, including patient satisfaction, as well as quality of life
  • Potential for medical cost offsets in direct total costs of care and the impact per member per year costs.
  • Potential productivity impacts of introducing patients to the new product
  • Product performance and cost-effectiveness data for up to three years

"Our purpose in sharing this information is to provide drug companies with a clear sense of what we are looking for and to encourage them to invest in research that will produce more meaningful information, which can be used by WellPoint, physicians and members to work toward better health and lower costs," Sweet said.

About WellPoint, Inc.

WellPoint is committed to improving the lives and health of the people and communities we serve by simplifying the connection between health, care and value. Our goal is to help shape the impact each health care decision has on individuals, the health care system at-large, and our communities. WellPoint's more than 42,000 associates work every day to help create the best health care value for our customers. Through collaborations with providers and with innovative programs, WellPoint's affiliated health plans reward healthy lifestyles and quality, safe and effective care. As the nation's largest health benefits company, with more than 35 million members in its affiliated health plans, WellPoint is at the center of the health care system. This position provides us with the relationships and insights needed to help create affordable and actionable solutions that improve health care.

As an independent licensee of the Blue Cross and Blue Shield Association, WellPoint serves members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as the Blue Cross Blue Shield licensee in 10 New York City metropolitan and surrounding counties and as the Blue Cross or Blue Cross Blue Shield licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at www.wellpoint.com.


'/>"/>
SOURCE WellPoint, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Insurance Industry Contributions to Politicians Block Regulation, Affordability in Health Care Debate, Says FTCR
2. THA Honors Nine Legislators for Contributions to Health Care
3. American Cancer Society Honors Outstanding Contributions to Fight Against Cancer
4. American Cancer Society to Present Highest Honor to Matthew L. Myers, Douglas R. Lowy, and Mark Schiffman for Outstanding Contributions to Cancer Fight
5. Will Rogers Institute to Honor Worlds Leading Geneticist and Recent Medal of Freedom Recipient, Dr. Francis S. Collins For His Outstanding Contribution to Lung Research.
6. Hooters of Gulfport Makes the Largest Contribution towards the $250,000 Donation to the V Foundation for Cancer Research
7. Childrens doctor honored by president of Colombia for contributions to pediatric cardiac care
8. Examination by National Expert Shows Blue Cross Blue Shield of Michigans Social Mission Contributions Totaled at Least $391 Million in 2007
9. MITs McGovern Institute honors Emory neuroscientist for contributions to psychiatry
10. UNIFEM and Avon Announce Partnership to End Violence Against Women and Advance Womens Empowerment: Company Contribution Benefits UN Trust Fund
11. Ford Launches Warriors in Pink Mustang for 09, Doubles Contributions To Race For The Cure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
Breaking Medicine Technology: